Literature DB >> 19286927

Ceramide-dependent PP2A regulation of TNFalpha-induced IL-8 production in respiratory epithelial cells.

Timothy T Cornell1, Vania Hinkovska-Galcheva, Lei Sun, Qing Cai, Marc B Hershenson, Susan Vanway, Thomas P Shanley.   

Abstract

IL-8 is a key mediator in the pathophysiology of acute lung injury. TNFalpha stimulates IL-8 production in respiratory epithelial cells by activating both the NF-kappaB and MAP kinase pathways. The precise mechanism by which these pathways are downregulated to terminate IL-8 production remains unclear. We studied the regulatory role of the serine/threonine phosphatase, PP2A, on the signaling pathways involved in IL-8 production from respiratory epithelial cells. Inhibition of PP2A using okadaic acid or gene knockdown using siRNA resulted in an augmentation of TNFalpha-induced IL-8 production. We also found that PP2A inhibition resulted in prolonged activation of JNK, p38, and ERK resulting in both increased transcriptional activation of the IL-8 promoter and posttranscriptional stabilization of IL-8 mRNA. Because TNFalpha had been shown to activate ceramide accumulation, and separate studies had linked ceramide with activation of PP2A, we hypothesized the pathway of TNFalpha-inducing ceramide to activate PP2A comprised an endogenous regulatory pathway. Inhibition of the immediate sphingomyelinase-dependent pathway as well as the de novo synthesis pathway of ceramide production reduced serine/threonine phosphatase activity and augmented IL-8 production. These data suggest that ceramide plays a role in activating PP2A to terminate ongoing IL-8 production. In summary, our data suggest that in respiratory epithelium, TNFalpha induces ceramide accumulation, resulting in subsequent activation of PP2A, which targets those kinases responsible for transcriptional activation of IL-8.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286927      PMCID: PMC2681348          DOI: 10.1152/ajplung.90516.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  48 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Regulation of human airway epithelial cell IL-8 expression by MAP kinases.

Authors:  Jing Li; Sreedharan Kartha; Svetlana Iasvovskaia; Alan Tan; Rajesh K Bhat; Joel M Manaligod; Kristen Page; Allan R Brasier; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-10       Impact factor: 5.464

Review 3.  Neutrophils and acute lung injury.

Authors:  Edward Abraham
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways.

Authors:  H Holtmann; R Winzen; P Holland; S Eickemeier; E Hoffmann; D Wallach; N L Malinin; J A Cooper; K Resch; M Kracht
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

5.  The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation.

Authors:  H Holtmann; J Enninga; S Kalble; A Thiefes; A Dorrie; M Broemer; R Winzen; A Wilhelm; J Ninomiya-Tsuji; K Matsumoto; K Resch; M Kracht
Journal:  J Biol Chem       Date:  2000-10-24       Impact factor: 5.157

6.  Mechanisms in fluoride-induced interleukin-8 synthesis in human lung epithelial cells.

Authors:  M Refsnes; E V Thrane; M Låg; G H Thoresen; P E Schwarze
Journal:  Toxicology       Date:  2001-10-15       Impact factor: 4.221

7.  The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling.

Authors:  T P Shanley; N Vasi; A Denenberg; H R Wong
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid.

Authors:  C E Chalfant; K Kishikawa; M C Mumby; C Kamibayashi; A Bielawska; Y A Hannun
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

9.  A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils.

Authors:  Natalie J Avdi; Kenneth C Malcolm; Jerry A Nick; G Scott Worthen
Journal:  J Biol Chem       Date:  2002-08-16       Impact factor: 5.157

Review 10.  Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

Authors:  S M Keyse
Journal:  Curr Opin Cell Biol       Date:  2000-04       Impact factor: 8.382

View more
  23 in total

1.  Protein phosphatase 2A activation attenuates inflammation in murine models of acute lung injury.

Authors:  Walker M McHugh; William W Russell; Andrew J Fleszar; Paul E Rodenhouse; Skyler P Rietberg; Lei Sun; Thomas P Shanley; Timothy T Cornell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

2.  Myeloid-Specific Gene Deletion of Protein Phosphatase 2A Magnifies MyD88- and TRIF-Dependent Inflammation following Endotoxin Challenge.

Authors:  Lei Sun; Tiffany T Pham; Timothy T Cornell; Kelli L McDonough; Walker M McHugh; Neal B Blatt; Mary K Dahmer; Thomas P Shanley
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

3.  Picfeltarraenin IA inhibits lipopolysaccharide-induced inflammatory cytokine production by the nuclear factor-κB pathway in human pulmonary epithelial A549 cells.

Authors:  Rong Shi; Qing Wang; Yang Ouyang; Qian Wang; Xudong Xiong
Journal:  Oncol Lett       Date:  2015-12-16       Impact factor: 2.967

4.  Protein phosphatase 2A promotes endothelial survival via stabilization of translational inhibitor 4E-BP1 following exposure to tumor necrosis factor-α.

Authors:  Carla Janzen; Suvajit Sen; Janis Cuevas; Srinivasa T Reddy; Gautam Chaudhuri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

5.  Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion.

Authors:  M P Ward; J P Spiers
Journal:  Br J Pharmacol       Date:  2017-04-07       Impact factor: 8.739

6.  Citrate modulates lipopolysaccharide-induced monocyte inflammatory responses.

Authors:  M J Ashbrook; K L McDonough; J J Pituch; P L Christopherson; T T Cornell; D T Selewski; T P Shanley; N B Blatt
Journal:  Clin Exp Immunol       Date:  2015-04-19       Impact factor: 4.330

7.  Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling.

Authors:  M Danielle Bareford; Hossein A Hamed; Jeremy Allegood; Nichola Cruickshanks; Andrew Poklepovic; Margaret A Park; Besim Ogretmen; Sarah Spiegel; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2012-06-07       Impact factor: 4.742

Review 8.  Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

Authors:  Christopher H Switzer; Sharon A Glynn; Lisa A Ridnour; Robert Y-S Cheng; Michael P Vitek; Stefan Ambs; David A Wink
Journal:  Trends Pharmacol Sci       Date:  2011-09-04       Impact factor: 14.819

9.  The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity.

Authors:  Adam Collison; Luke Hatchwell; Nicole Verrills; Peter A B Wark; Ana Pereira de Siqueira; Melinda Tooze; Helen Carpenter; Anthony S Don; Jonathan C Morris; Nives Zimmermann; Nathan W Bartlett; Marc E Rothenberg; Sebastian L Johnston; Paul S Foster; Joerg Mattes
Journal:  Nat Med       Date:  2013-01-20       Impact factor: 53.440

10.  Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.

Authors:  Gabriella Wojewodka; Juan B De Sanctis; Danuta Radzioch
Journal:  J Lipids       Date:  2010-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.